Blackstone Inc
ACET icon

Blackstone Inc’s Adicet Bio ACET Stock Holding History

Blackstone Inc’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-77,278
Closed -$934K – 169
2025
Q1 		$934K Hold
77,278
– – ﹤0.01% 122
2024
Q4 		$1.19M Hold
77,278
– – 0.01% 123
2024
Q3 		$1.78M Hold
77,278
– – 0.01% 115
2024
Q2 		$1.5M Hold
77,278
– – 0.01% 125
2024
Q1 		$2.91M Buy
+77,278
New +$3.2M 0.01% 108

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Blackstone Inc's ACET Position: Q2 2025 in Review

Blackstone Inc sold out of Adicet Bio (ACET) in Q2 2025, closing a stake of 77,278 shares — an estimated $934K sold.

Blackstone Inc first reported a position in ACET in Q1 2024 and held it in 5 quarters. The position peaked at $2.91M in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q2 2025.

  • Blackstone Inc reported no remaining Adicet Bio position as of Q2 2025 after selling out during the quarter.
  • Blackstone Inc sold 77,278 Adicet Bio shares in Q2 2025, an estimated $934K.
  • Blackstone Inc first reported a position in Adicet Bio in Q1 2024 and held it in 5 quarters.
  • Blackstone Inc's Adicet Bio position peaked at $2.91M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2025.

Based on Blackstone Inc's 13F filing for Q2 2025, filed 14 Aug 2025.